|
Australia – a world class partner in biotechnology
Australia has a diverse biotechnology sector with over 460 core biotech companies covering human therapeutics, agriculture, bioinformatics and convergent technologies such as nano-biotechnology applications. Within human therapeutics Australia has world-class excellence in immunology, stem cells, reproductive medicine, infectious diseases, and oncology, as well as cross-sectoral areas, such as proteomics. Read more.
International organisations seeking innovative Australian biotechnology expertise are invited to request an introduction to Australian companies.
Using this service, your organisation can:
- View the list of exhibitors on the BIO 2009 Australian Pavilion.
- Request meetings with Australian companies of interest directly with their key business development managers.
Over 10 innovative Australian leading edge bioscience companies will be at the(booth number 2133) at BIO 2009. AusBiotech is coordinating the Australian Pavilion.
A leading provider of innovative tissue engineering solutions is emerging in the heart of Melbourne’s biotech hub. The Australian Tissue Engineering Centre is a collaborative facility that brings world-class stem cell, biomedical engineering and microsurgery research bodies together to drive the delivery of benefits from Australia’s world-class tissue engineering research. Read more.
Axxin provides platforms and diagnostic medical devices for biomedical applications that bridge the gap from chemistry to market with world leading innovation, capability and cost effectiveness. The company's goal is to take the cost and complexity out of point of care diagnostics, near patient and bio-appliance applications. Read more.
BioGeelong and the City of Greater Geelong are working to promote and grow the local Biotech Industry. The Geelong Region, located ~1 hours drive from Melbourne (Victorian State Capital), has the largest Biotechnology capability in Victoria outside Melbourne. The Geelong Biotechnology Precinct boasts significant infrastructure of national and international significance. Read more.
Australia’s Griffith University, Queensland is a regional leader in biotechnology with the Eskitis Institute, Institute for Glycomics and Genomics Research Centre. These centres collaborate with key industry and public sector health partners to deliver research benefits to the community through outcomes such as novel therapies, diagnostics, and analytical services. Read more.
Invetech provides innovative contract development and manufacture for instruments, devices, consumables and custom automation. For more than 30 years, we have worked with leading companies that provide instrument systems for laboratory and research applications; and custom automation and integration for research or production processes. Our in-house team of 200+ professionals use systematic ISO 9001, IEC 60601, IEC 61010, QSR compliant development processes and FDA registered manufacturing facilities, to deliver high quality, fast-to-market results. Read more.
MiniFAB, a private company, offers contract product development, prototyping and manufacturing for the biotechnology sector. We specialize in the realization of customized solutions based on polymer micro and nano engineering. Application areas include: diagnostics; laboratory instrumentation; environmental monitoring; microfluidics; sample preparation; and medical devices. Working with clients, we develop product strategies, create manufacturing methods, and provide manufacturing solutions all within an ISO13485 environment. Read more.
The NSW Clinical Trials Business Development Centre (ClinicalTrialsNSW) supports local and international organisations and researchers with the conduct of their clinical trials in Sydney Australia. ClinicalTrialsNSW provides advice on how to conduct trials in Australia, assists with site identification and introduction to local service providers, acts as an independent advisor and resource centre. Read more.
Nucleus Network is Australia’s leading clinical research organisation for the conduct of Early Phase Clinical Trials— its people, facilities and problem-solving culture provide excellent service to global pharmaceutical and biotechnology companies. Read more.
QRxPharma Ltd. (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders. The Company’s lead products comprise a patented combination of existing drugs, with a well-defined path to regulatory approval and sales. QRxPharma’s lead drug compound, MoxDuo™ IR (Q8003IR), began Phase III clinical trials in November 2007. The Company’s preclinical and clinical pipeline includes other technologies in the fields of neurodegenerative disease and venomics. Read more.
Queensland University of Technology (QUT) is a contemporary industry related University enrolling around 40,000 students. Our real-world focus has earned QUT a powerful reputation for working successfully with business, industry and the community. Our programs transcend academic boundaries to help solve real-world problems and provide training, consultancies and academic programs that achieve great outcomes. Read more.
Seagull Technology’s unique platform drug delivery device is designed for the non-invasive delivery of drugs by an innovative combination of nanotechnology and ultrasound. In its first application, it will facilitate a safer and more comfortable delivery of drugs to the back of the eye to manage diseases such as Age Related Macular Degeneration (ARMD). Currently injections directly into the eye are required every 6-8 weeks to prevent blindness. Injection complications include infection, haemorrhage and retinal detachment. Read more.
Selborne Biological Services is a leading supplier of specialized products of animal origin for the biotech, pharmaceutical, veterinary, and diagnostics industries. Selborne has been producing high quality biological products for more than 30 years. Its operations now span three continents, with offices in Australia, Europe, and North America. Selborne's principal manufacturing facilities are located in the rural community of Longford on the northern end of Tasmania, Australia's magnificent island state. Read more.
The University of Queensland’s Institute for Molecular Bioscience, Queensland Brain Institute, Australian Institute for Biotechnology & Nanoengineering and Diamantina Institute for Cancer, Immunology & Metabolic Medicine hold nearly 1,000 researchers, and combine leading facilities with a culture of research excellence and technology transfer. Read more.
Trident Clinical Research is an independent Australian full service CRO providing contract research services since 1997. Trident has clinical research staff based in Sydney, Melbourne, Adelaide, Brisbane, Perth and Mumbai, India. Read more.
UniQuest Pty Limited at The University of Queensland UniQuest is widely recognized as one of Australia’s largest and most successful university commercialization groups. For almost 25 years UniQuest has been managing and commercializing an extensive intellectual property portfolio, including core technologies in vaccine development and diagnostic devices. Read more.
|